Skip to main content
. 2015 Jun 26;8:1581–1588. doi: 10.2147/OTT.S84994

Figure 2.

Figure 2

Survival curve for patients with mRCC.

Notes: (A) OS curve for all patients and the median OS was 16.1 months. (B) PFS curve for all patients and the median PFS was 10.5 months.

Abbreviations: mRCC, metastatic renal cell cancer; OS, overall survival; PFS, progression-free survival.